GONUTS has been updated to MW1.31 Most things seem to be working but be sure to report problems.

Have any questions? Please email us at ecoliwiki@gmail.com

PMID:22357623

From GONUTS
Jump to: navigation, search
Citation

Li, P, Goto, H, Kasahara, K, Matsuyama, M, Wang, Z, Yatabe, Y, Kiyono, T and Inagaki, M (2012) P90 RSK arranges Chk1 in the nucleus for monitoring of genomic integrity during cell proliferation. Mol. Biol. Cell 23:1582-92

Abstract

The ataxia telangiectasia mutated- and rad3-related kinase (ATR)/Chk1 pathway is a sentinel of cell cycle progression. On the other hand, the Ras/mitogen-activated protein kinase/90-kDa ribosomal S6 kinase (p90 RSK) pathway is a central node in cell signaling downstream of growth factors. These pathways are closely correlated in cell proliferation, but their interaction is largely unknown. Here we show that Chk1 is phosphorylated predominantly at Ser-280 and translocated from cytoplasm to nucleus in response to serum stimulation. Nonphosphorylated Chk1-Ser-280 mutation attenuates nuclear Chk1 accumulation, whereas the phosphomimic mutation has a reverse effect on the localization. Treatment with p90 RSK inhibitor impairs Chk1 phosphorylation at Ser-280 and accumulation at the nucleus after serum stimulation, whereas these two phenomena are induced by the expression of the constitutively active mutant of p90 RSK in serum-starved cells. In vitro analyses indicate that p90 RSK stoichiometrically phosphorylates Ser-280 on Chk1. Together with Chk1 phosphorylation at Ser-345 by ATR and its autophosphorylation at Ser-296, which are critical for checkpoint signaling, Chk1-Ser-280 phosphorylation is elevated in a p90 RSK-dependent manner after UV irradiation. In addition, Chk1 phosphorylation at Ser-345 and Ser-296 after UV irradiation is also attenuated by the treatment with p90 RSK inhibitor or by Ser-280 mutation to Ala. These results suggest that p90 RSK facilitates nuclear Chk1 accumulation through Chk1-Ser-280 phosphorylation and that this pathway plays an important role in the preparation for monitoring genetic stability during cell proliferation.

Links

PubMed PMC3327324 Online version:10.1091/mbc.E11-10-0883

Keywords

Cell Cycle; Cell Cycle Proteins/metabolism; Cell Line, Tumor; Cell Nucleus/metabolism; Cell Proliferation; Cytoplasm/metabolism; Genomic Instability; HeLa Cells; Humans; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases/metabolism; Phosphorylation; Protein Kinases/genetics; Protein Kinases/metabolism; Protein Transport; Protein-Serine-Threonine Kinases/metabolism; Proto-Oncogene Proteins c-akt/metabolism; RNA Interference; RNA, Small Interfering; Ribosomal Protein S6 Kinases, 90-kDa/antagonists & inhibitors; Ribosomal Protein S6 Kinases, 90-kDa/genetics; Ribosomal Protein S6 Kinases, 90-kDa/metabolism

Significance

Annotations

Gene product Qualifier GO Term Evidence Code with/from Aspect Extension Notes Status

HUMAN:KS6A1

GO:0004674: protein serine/threonine kinase activity

ECO:0000314:

F

Figure 5

complete
CACAO 6570

HUMAN:KS6A1

enables

GO:0004674: protein serine/threonine kinase activity

ECO:0000314: direct assay evidence used in manual assertion

F

Seeded From UniProt

complete


See also

References

See Help:References for how to manage references in GONUTS.